SAN FRANCISCO -- Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses, today announced that it has signed a definitive agreement to acquire the STARLIMS informatics product suite and related business assets from Abbott (NYSE: ABT). Abbott is a global healthcare company with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Terms of the transaction were not disclosed.
A world-class Laboratory Information Management System (LIMS) solution, STARLIMS is a product suite that improves both quality and safety for organizations throughout the entire product lifecycle, beginning with R&D. For more than 35 years, STARLIMS software solutions have helped organizations to manage the collection, processing, storage, retrieval and analysis of information generated in laboratories.
Since 1986, the STARLIMS business has accelerated worldwide sales growth to now serve more than 1,100 customers across 60 countries spanning the Americas, Europe, Africa, and Asia. Today, STARLIMS solutions are used by top companies in the life sciences, pharma & biotech, chemical & refining, food & beverage, manufacturing, environmental, public health and forensics sectors.
“The STARLIMS technology is a leader in data and workflow management for laboratories across the globe. With the constantly changing landscape of quality manufacturing coupled with substantial industry tailwinds, we believe the business is well positioned for continued growth as it supports its customers through the entire product lifecycle from R&D and trials through manufacturing and compliance,” said Ezra Perlman, Co-President of Francisco Partners. “We are excited to support STARLIMS in its next phase of growth, and we look forward to helping the business further evolve its innovative product suite to meet the needs of its customers while maintaining its industry-leading safety and compliance standards.”
“As a global leader in laboratory informatics, the STARLIMS business brings organizations a set of solutions that helps laboratories deliver safe, high quality products on-time and on-budget to ultimately fuel growth,” said Ali Evans, Vice President at Francisco Partners. “For more than a decade, STARLIMS has thrived within Abbott’s informatics business, and we are excited to partner with the employees and customers to further build on a history of leadership with the Laboratory Information Management System industry.”
About Francisco Partners
Francisco Partners is a leading global investment firm that specializes in partnering with technology and technology-enabled businesses. Since its launch over 20 years ago, Francisco Partners has invested in more than 300 technology companies, making it one of the most active and longstanding investors in the technology industry. With more than $25 billion in assets under management, the firm invests in opportunities where its deep sectoral knowledge and operational expertise can help companies realize their full potential. For more information on Francisco Partners, please visit www.franciscopartners.com.
About STARLIMS
STARLIMS is a comprehensive and worldclass Laboratory Information Management System (LIMS) solutions suite that helps organizations move from managing data in silos to delivering integrated, meaningful, and intelligent information that supports lab workflow and business value. From R&D and clinical trials to manufacturing and beyond, STARLIMS solutions improve quality and safety throughout the entire product lifecycle.
For more than 35 years, STARLIMS has been deployed in top companies in the life sciences, pharma & biotech, chemical & refining, food & beverage, manufacturing, environmental, public health and forensics sectors, with industry specific workflows. For more information about STARLIMS, please visit https://www.starlims.com/us/en/offerings/lims.
ABOUT STARLIMS
STARLIMS helps organizations move from managing data in silos to delivering integrated, meaningful, and intelligent information that supports lab workflow and business value while also improving quality and safety across the entire product life cycle. The company serves more than 1,100 customers across 60 countries in industries such as life sciences, pharma & biotech, chemical & refining, food & beverage, and manufacturing.